Home>Topics>Companies>Express Scripts

Express Scripts ESRX

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. Morningstar's Most Popular

      Headlines

      Fri, 21 Nov 2014

      IBM Berkshire Hathaway Alibaba Group Halliburton Most Requested Stock Analyses Lexicon Apache Procter & Gamble Halliburton Express Scripts Most Requested Fund Quotes Vanguard Wellington Fidelity Contrafund Vanguard Dividend Growth Vanguard 500 Index Vanguard

    2. Berkshire invests in Express Scripts , makes confidential disclosure

      Headlines

      Fri, 14 Nov 2014

      Nov 14 (Reuters) - Warren Buffett's Berkshire Hathaway Inc disclosed a new stake in healthcare management company Express Scripts Holding Co and shed its stake in agricultural equipment maker Deere...

    3. Purchase of Express Scripts and Sale of Deere the Most Notable Changes in Berkshire's 3Q Portfolio

      Commentary

      Fri, 14 Nov 2014

      more than two thirds of the portfolio. The insurer's only new money purchase during the period was 450,000 shares of Express Scripts for an estimated cost of around $32 million. Berkshire also more than doubled its stake in Charter Communications (making

    4. Berkshire Likes Express Scripts --and So Do We

      Headlines

      Fri, 14 Nov 2014

      more than two thirds of the portfolio. The insurer's only new money purchase during the period was 450,000 shares of Express Scripts ESRX for an estimated cost of around $32 million. Berkshire also more than doubled its stake in Charter Communications

    5. Express Scripts Well Positioned for New Health-Care Order

      Headlines

      Fri, 31 Oct 2014

      and dominant market position, Express Scripts ESRX is significantly undervalued ..... Given these factors, we believe Express Scripts will produce robust economic profits over the long term. Express Scripts reported third-quarter results

    6. Express Scripts says AbbVie drug could displace Sovaldi on formulary

      Headlines

      Wed, 29 Oct 2014

      Oct 29 (Reuters) - Pharmacy benefit manager Express Scripts Holding Co said it may quickly change its preferred drug formulary to favor an expected new hepatitis C drug from AbbVie if it

    7. BRIEF- Express Scripts says may change formulary in mid-2015 due to "unsustainable" cost of Gilead's Sovaldi

      Headlines

      Wed, 29 Oct 2014

      Oct 29 (Reuters) - Express Scripts Holding Co : * Says may change drug formulary in mid-2015 to favor expected new hepatitis c

    8. Express Scripts Reports Solid 3Q Results; Medco Integration On Track; Shares Still Undervalued

      Commentary

      Wed, 29 Oct 2014

      Express Scripts reported third-quarter results that were largely in line with our expectations, and we are reiterating our $89 fair value estimate

    9. Glaxo Posts Largely In-line 3Q with SG&A Cost Cuts Mitigating Pricing Pressure in Respiratory Drugs

      Commentary

      Wed, 22 Oct 2014

      moat. However, we expect the decline to slow in 2015 as new respiratory drugs gain traction and new contracts begin with Express Scripts (top drug Advair will be removed from the "exclude" list in 2015) and Caremark (competing drug Symbicort will be added

    10. Health Care: Some Healthy Bargains Still Remain

      Headlines

      Wed, 1 Oct 2014

      39.90 Baxter $84.00 Wide Low $67.20 Express Scripts $89.00 Wide Medium $62.30 Data as of ..... charge a price premium over competitors. Express Scripts ESRX Express Scripts is the largest pharmacy benefit manager in

    « Prev12345Next »
    Content Partners